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Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         6                                                      Original Article     In Vivo Antimalarial Effects of Iranian Flora  Artemisia   khoras - sanica  against  Plasmodium berghei  and Pharmacochemistry of its  Natural Components     * H Nahrevanian 1 , B Esmaeili 2 , M Kazemi 3 ,    H  Nazem 2 , M Amini 1     1  Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran   2  Payame Nour University, Tehran Center, Tehran, Iran   3  Department of Applied Chemistry, Islamic Azad University, Qom Branch, Iran     (Received 21 May 2009; accepted 15 N ov 2009)   Abstract   Background :   The aim of this study was to evaluate the antimalarial effects of Iranian flora  Artemisia  khorassanica  against  Plasmodium berghei   in vivo  and pharmacochemistry of its natural components.   Methods :  The aerial parts of  Iranian fl ora  A. khorasanica  were collected at flowering stage from  Khorassan Province, northeastern Iran  in 2008 . They were air - dried at room temperature ;   powder  was   macerated in methanol and the extract defatted in refrigerator, filtered, diluted with water, then  eluted  with n - hexane and finally non - polar components were identified through  Gas Chromatography and  Mass Spectroscopy   (GC - MS) .   Toxicity of herbal  extracts was assessed on naïve NMRI mice ,  and  its  anti - malarial efficacy was investigated on  infected  Plasmod ium berghei   animals .  This is the first  ap - plication  on  A. khorssanica   extract  for  treatment of murine malaria .  The significance of differences  was determined by Analysis of Variances (ANOVA) and Student’s  t - test using Graph Pad Prism  Software.   Results :  The  herbal extract was successfully tested  in vivo  for its anti - plasmodial  activity through  a r - temisin composition, which is widely used as a standard malaria treatment.   Conclusion :   Although, this study confirmed less anti - malarial effects of  A.  k horssanica  a gainst mur - ine malaria  in vivo , how ever there are  some  e vidences  on reducing pathophysiolog y  by this medica - tion.  In  complementary  assay, m ajor components were detected  by GC - MS analysis  in   herbal  extract  including  chrysanthe none (7.8 % ), palmitic acid (7 .4 % )  and  cis - thujone (5.8 % ).     The most retention  indices of the compo nent are given as n - eicosane, palmitic acid and n - octadecane.   Keywords :  Artemisia khorassanica ,   Iran ,  Malaria ,  Pharmacochemistry ,   Plasmodium  berghei                                             *   Corresponding Author :  Tel/Fax: (0098 - 21) 66968855,  E - mail:   mobcghn@pasteur.ac.ir         Iranian J Parasitol   Open access Journal at   http:// ijpa.tums.ac.ir       Tehran University of Medical  Sciences Publ i cation   http:// tums.ac.ir     Iranian Society of  Par a sitology   http:// isp.tums.ac.ir  Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         7   Introduction     alaria,  is  one of  the most serious  and  wide spread  diseases  en - countered by  human.  It  is  an in - fectious  disease  caused  by  the  para site  Plasmodia (P.)   transmitted by the fe male  anopheles mosquitoes.  Four identi fied spe - cies of this parasite exist, which cause dif - ferent  t ypes  of  human  malaria  ( 1 ) .  Al - though all the four species of malaria para - sites can   infect humans and cause ill ness,  only  P.  falciparum  is known to be poten - tially  life  threatening  and  some  of infected  persons  die,  usually  because  of  delayed  treatment  ( 2 ) . An  annual incidence of 300 - 500 million  clinically  cases and  1 - 2  mil - lion  death occur in the world  ( 3 - 6 ) .     As  malaria  vaccines  remain  problematic,  chemotherapy  still  is  the  most  important  weapon in the fight against the disease  ( 7 ) .  The  antimalarial  drugs   including  chloro - quine, quinine, mefloquine, pyrimethamine  and artemisinine are currently used to pre - vent and treat human malaria.  Part of the  reason for the failure to control malaria ,  is  the  spread  of  resistance  to  first - line  anti - malarial  drugs,  cross - resistance  between  the limited   number of drug families avail - able,  and  some  multidrug  resistance   ( 8 ) .   Resistance  has  emerged  to  all  classes  of  antimalarial  drugs  except  artemisinin,  an  endoperoxide antimalarial drug derived as  the active component of  Arte misia annua ,   a  herbal  remedy  used  in  Chinese  folk  medicine  for  2000  years  " qinghaosu "   ( 9 - 12 ) .   Artemisinin is a powerful anti - malarial  drug  with  significant  activities,  which   is   resistant  to  chloroquine.  It  is  a  natural  product,  which   has  the  characteristic s  of  high  potency  against  the  parasite  whilst  possessing low toxicity during treatment of  malaria infections  ( 13 - 15 ) .   The  genus  Artemisia   has  always  been  of  great pharmaceutical  interest and is useful  in traditional medicines for a treatment of  the variety  of diseases   ( 11, 16, 17 ) .   A. an - nua   is  presently  being  cultivated  on  a  commercial  scale  in  China  and  Vietnam  for  its  antimalarial  sesquiterpene  lactone.  The  genus  is  of  small  herbs  found  in  Northern temperate regions and belongs to  the  important  family  Co mpositae  (As - teraceae),  one  of  the  most  bulky  vegetal  groupings,  which  comprises  about1000  genera  and  over  20,000  species.  Within  this family,  Artemisia  is included into the  family   Anthemideae  and  comprises  itself  over  400  species,  found  in  Europe  and  Nort h  America,  but mainly are dominating  the  Asia   ( 18 - 20 ) .  Among  the  Asian  Ar - temisia   flora,  150  species  were  recorded  for China, 50 species reported to occur in  Japan  and  34  species  of  the  genus  are  found in Iran, of which  may be  endemic;  A. melanolepis Boiss  and  A. kermanensis  Pold    ( 21 ) ,  A. absinthium   ( 22 ) ,    A. annua   ( 23 ) ,  A. dracunculus  ( 24 ) ,  A . aucheri  ( 25 ) ,   A.  haussknechtii  Boiss  ( 26 ) ,   A.  scoparia,  A. sieberi     ( 27 )  and   A. sieberi Besser  ( 28 ) .   Pharmacochemical analysis of  a rtemisin in   shows that t he structu re of this compound  is rather unique among natural products  as   it contains the very unusual 1, 2, 4 - trioxane  ring  system.  It  was  sufficiently  unusual  that  it  was  originally  characterized  as  an  ozonide  until  revised  crystallographic  analysis  provided  unambi guous  structural  elucidation  ( 29 - 33 ) .   For a drug to be effective against the ma - laria parasite, it must reach the site of ac - tion  in  sufficient  concentration  and  then  interact with  the  receptors before it is ei - ther  deactivated  and/or  eliminated  by  the  hos t or the parasite. Extensive pharmacol - ogical and biochemical evaluation revealed  that this compound was a blood schizonti - cide  preferentially  imported  into  malaria - infected   erythrocytes  via  the  parasitopho - rous duct  ( 34 ) . It has been also shown that  artem isinin  and  related  trioxanes  demon - strate useful activity against selected carci - nomas  ( 35 ) .  Due  to  complex  chemical  structure of artemisinin, the chemical syn - thesis of the molecule is complex, which  results in very low yields and the cost be - M   Nahrevanian et al.: In Vivo Antimalarial Effects of…  Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         8   comes  prohib itory  to  use  synthetic  ap - proach for its commercial production  ( 36 ) .    The mechanism of the action of artemisi - nin remains a mystery, although iron ap - pears  to  be  involved  in  activating  this  endoperoxide  to  generate  cytotoxic  free  radicals  ( 37 ) . Several can didates have been  hypothesized  as  targets  of  artemisinins,  including  haem  and   some  parasite  mem - brane proteins  ( 37 – 39 ) ,   however;   none of  these  has  been convincingly shown to be  functionally  relevant.  Recently,  some  re - searcher   proposed  Pf ATP6 ,  as   artemisi - nin’s  target ( 40 ) ; however, this conclusion  has also been debated  ( 41 ) .   For a better understanding of specific frac - tions with high efficacy and low side effects,  chemical  analysis  of  genus  of  Iranian  A .   khorassanica   was  required.  Pharmaco - chemistry and ch emical analysis of different   genus  of Iranian  Artemisia  species  has been  studied and  the  presen ce  of  variety of com - ponents  including  monoterpenes  ( 42 ) ,  ses - quiterpenes  ( 43 ,  44 ) ,   sesquiterpene lactones  ( 42 , 45, 46 )  and essential oils  ( 47 - 51 )  were  fully  rep orted   ( 22 - 28 ) .   This genus is  uniform   and  the  chemistry  is  somewhat  diverse.  However,  most  species  contain  sesquiter - pene  lactones,  especially  11,13 -   dihydro  derivatives   ( 42 - 51 ) .   The aim of this study was to evaluate Iranian  flora  A .   khorassanica   for  its  an timalarial  effects against  Plasmodium berghei   in vivo   and pharmacochemical analysis of its natural  components.  This  is  the  first  report  on  A .  khorasanica   extract  as  flora  from  the  Khorassan  Province,  northeastern  Iran  for  treatment  of murine  malaria  on   P .   berghei   infected NMRI mice .   The  major components  were  also  detected by  Gas Chromatography  and Mass Spectroscopy ( GC - MS )  analysis.      Materials and  M ethods     P lant samples   The  aerial  parts  of  Iranian  flora  A.  khorasanica   were  collected  at  flowering  stage  from   their  natural  habitats  the  Shahro u d  Mountains  in  Khorassan   P rov - ince ,   northeastern  Iran   in  2008 .  Voucher  specimens  were  deposited  and identified  at  the  H erbarium of the Research Institute of   Forests  and  Rangelands   (RIFR) ,  Tehran ,  Iran.     Extraction  of  Herb al  Extract  and  Non - polar Compounds   The  aerial  parts  were  air - dried  at  room  tem perature and were then powdered .   The  herbs  powder (650 g)  of A.  khorassanica  was  macerated in methanol   (1 lit) and sub - sequently  kept  for 48 - 72   h.  It was then f il - tered and evapo rated at reduced pressure  to  give a crude extract  (50 ml).  The extract  was  defatted at  - 15°C in refrigerator ,  fil - tered ,  added  with  water   (20%  w/w )  and   then elut ed with n - hexane (50  ml ).  Finally,  n - hexane p hase  was collected,  evaporated  by rotary evaporato r (20 ml)  and then  non - polar components were identified through  GC - MS analysis   ( 52 ) .    Gas  Chromatography  (GC):  GC  analysis  was  performed  on  a  Shimadzu  15A  gas  chromatograph equipped with a spilt / spilt  less  (ratio  1:30),  injector  (250°C)  and  a  flame ioniz ation detector (250°C). N 2  was  used  as  carrier  gas  (1  mL/min)  and  the  capillary column used was DB - 5 (50 m x  0.2 mm, film thickness 0.32 pin). The col - umn temperature was kept at 60°C for 3  min  and  then  heated  to  220°C  with  a  5°C/min rate and kept  constant  at 220°C  for  5  min.  Relative  percentage  amounts  were  calculated  from  peak  area  using  a  Shimadzu C - R4A chromatopac without the  use of correction factors   ( 53 ) .    GC/Mass  Spectrometry  (MS):  GC/MS  analysis  was  performed  using  a  Hewlett - Packard  (HP - 6890)   with  a   HP - 5MS  col - umn (30 m x 0.25 mm, film thickness 0.25  µm). The column temperature was kept at  60°C for 3  min, programmed to 220°C at a  rate  of  5°C/min,   and  kept  constant  at  220°C for 5 min. The flow rate of Helium  as carrier gas was (1 mL/min). MS were  take n at 70 eV, mass rang, 30 to 350  amu  and scan time, 2 scan/ sec  ( 53 ) .    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         9   Identification  of  components:  The  com - ponents  of  the  oil  were identified  by  comparison  of  their  mass  spectra  with  those  of  a  computer  library  or  with  au - thentic  compounds  and  confirmed  by  comparison of their retention indices either  with  those  of  authentic  compounds    or   with  data  published  in  the  literature  ( 54 ) .    The  retention  indices  were  calcu - lated  for  all  volatile  constituents  using  a  homologous series of n - alkanes  ( 53 ) .       Animals   Male outbred  NMRI  ( Naval Medical Re - search  Institute )   mice  (supplied  by  the  Laboratory  Animal  Department,  Karaj   Production,   and  Research  Complex ,  Pas - teur  Institute  of  Iran)  were  used  in  this  study. The mice were housed at room tem - perature  (20 – 23°C) on a 12   h light and 12  h dark cycle, with unlimited access to food  and tap water .     Ethical considerations   Experiments  with  animals  were  done  ac - cording to the ethical standards formulated  in the Declaration of Helsinki, and meas - ures taken to pr otect animals from pain or  discomfort. It has been approved by insti - tutional  ethical  review  board  (Ethical  Committee of the Pasteur Institute of  Iran),  in which the antimalarial test was done.       Malaria parasite   P .  berghei  NY  was  kindly donated by Dr.  M.  J. Dascombe from the School of Life  Sciences,  University  of  Manchester,  UK.  Malaria parasite was maintained by blood  passage in NMRI mice when active para - sites were required; otherwise it was stored  at  - 70°C  in  Alserver’s  solution  (2.33%  glucose,   0.525 % N aCl  and 1% sodium cit - rate in deionised water )  and glycerol (9:1  parts by volume)   ( 54 ) .     Inoculation of malaria parasites     Mice  were  inoculated  (0.2  ml )  intrave - nously ( iv) into a tail vein with blood from  a donor mouse ( 38 % parasitaemia  P. berg - hei ) dilut ed with 0.85% saline to contain   2×10 6  parasitised red blood cells (PRBC).     Experiments and groups     A )   Toxicity assay of  A. khorassanica   herbal extract  in naïve animals   In  vivo  toxicity  was   assessed  by  using  herbal extract   on naïve NMRI   male  mice .  Animals   were   divided  into  four  groups  (n= 8  mice/group), including Group 1 (na - ïve), Group 2 (low dose) ,  Group 3 (aver - age dose), Group 4   (high dose).  A sample  of  herbal  extract were  suspended in etha - nol and normal saline (1:9), then three dif - ferent  concentrations  (l ow,  average  and  high doses)  of herbal extracts including  1 ,  10   and  1 00  mg/ml  were tested  in vivo  for   its   toxicity   as  test  animals  and  a  control  group  which was injected with drug  vehi - cle . Entire animals in  all  groups  were in - jected  with 200 µl of  related  solutions   sub - cutaneously ( sc )   once a day  for 8 days.       B )   Anti - malarial effects of herbal ex - tract on  P. berghei  infected  mice   Following toxicity assay, the high est  dose   with the lowest toxicity  of  herbal  extract  (100 mg/ml concentrati on)    was selected  to  apply   for  its   antimalarial  activity  on  male  NMRI   mice infected with  P. berghei .  Animals   were  divided  into  two  groups   (n=10 mice/group), including  c ontrol  and  t est ;  both groups were infected with  mur - ine malaria parasite,   P. berghei .  D rug ve - hicle  and  herbal  extract  was  injected  sc  into  control  and  test  gr oups  respectively  once a day with 200 µl of solutions for the  period of three weeks.      Assessment of pathology     Parasitaemia   The  clinical  diagnosis  was  confirmed  by  laboratory  demonstration  of  the  malaria  parasite in the stained smears. In all  ani - mals,  pa rasitaemia was determined on dif - ferent  days  after  infection  using  blood  smears stained with Geimsa stain (Sigma  Nahrevanian et al.: In Vivo Antimalarial Effects of…    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         10   Chemical Co., USA). PRBC were counted  in  five  different  fields,  each  of  approxi - mately 200 cells. Results are expressed as  the  mean  percentage  (%)  of  erythrocytes  containing  Geimsa  bodies .  Experiments  were  licensed  under  the  Animals  (Scien - tific Procedures) Act 1986. In compliance  with the conditions of this license, infected  animals were humanely killed at the onset  of the terminal phase of mala ria ( P. berg - hei  ) infection   ( 54, 55 ) .     Assessment  of  degree  of  hepato/  splenomegaly   Entire  livers  and  spleens  were  removed  post mortem at the end of the experimental  period from mice after induction of termi - nal  general  anaesthesia  by  inhalation  of  diethy l  ether  (Sigma  Co.,  Germany).  Or - gan wet weights were measured and com - pared with controls as indices for degree of  hepatomegaly and splenomegaly   ( 5 6 ,  5 7 ) .     Body weight   Body weight was measured initially and at  different  times  of  experiment  (days  1,  7,  21)   using  a  top  pan  balance  (OHAUS  Scale Corp., USA)  as a major indication of  pathology  ( 56 ,  6 7 ) .     Statistical analysis   Values are presented as the mean ± SEM  for groups of  n  mice. The significance of  differences was  determined by  Analysis of  Variances  (ANOVA )  and  Student’s  t - test  using Graph   Pad Prism Software   (Graph - Pad, San Diego, California, USA).     Results     The results of toxicity assay in naïve mice  indicated  no significant pathophysiological  changes  in  body weight and splenomegaly   in test groups  as compa red with those in  control  after  injection of low, average and  high  doses  of  A.  khorassanica   crude  ex - tract s .  There  was   a  small  reduction  ( P <0.05)  in  hepatomegaly  of  test  groups   injected with low and high doses of herb al   crude extract , which emphasises the  anti -   symptomatic  effects  of  A.  khorassanica   (Fig .  1) .   The  clinical  diagnosis  of   P.  berghei  infection   was  confirmed  by  laboratory  demonstration  of  the  malaria  parasite  in  the  stained  smears.  Parasitaemia  was  de - termined using blood smears stained with  Geim sa stain   from mice   ( Fig .  2 ) .   The ob - servations  specifically  indicated  the  in - hibitory effects of the  A. khorassanica  ex - tracts on the early developmental stages of  P.  berghei   by  decreasing  parasitaemia  ( P <0.01).   Th is may  suggest that the active  constituen ts  in the  herbal  extract may be  toxic  for  P.  berghei ,  thereby  inhibiting  their development to the erythrocytic stage   (Fig .  3) .   No  pathophysiological  changes  including  body  weight,  hepatomegaly  and  splenomegaly   were detected in control and  malarial  groups  a s  induction  markers  for  toxicity after injection of crude extract of  A.  khorassanica   in  malarial  infected  ani - mals  (Fig .  4).   The  chemical analysis  of  extract by  GC - MS on a HP - 6890 instrument resulted in  isolation of  31  fractions and identification  of  effec tive  component s .  The  non - polar  components  obtained  from  extract  A.  khorassanica   are  listed  in  Table  1,  in  which the percentage and retention indices  of  the  component  are  given.  Nineteen  compounds, representing 53.7% of the to - tal  constituents  in  the  non - po lar  com - pounds  of  A.  khorassanica   were  charac - terized  by  chrisanthenone  (7.8%)  and  palmitic  acid  (7.4%).  Monoterpenes  con - stitute  the  major  fraction  of  the  oil  (29.9%),  while  sesquiterpenes  and  other  compounds accounted to 6.2% and 17.6%  respectively.        Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         11   Body Weight Start day End day 0 10 20 30 40 50 control Low dose Average dose High dose Body weight (gram) Hepatomegaly Contrtol Low does Average dose Hige dose 0.0 0.5 1.0 1.5 2.0 2.5 3.0 * * Entire liver weight (gram) Splenomegaly Control Low dose Average dose High dose 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 Entire spleen weight (gram)       Fig. 1:  Toxicity assay and  pathophysiological changes induced by  A. khorassanica  crude ex - tract in naive animals   Pathophysiological changes including body weight, hepatomegaly and  splenomegaly   were evaluated in control and test groups as toxicity ass ay induced by injection  of low, average and high doses of  A. khorassanica  crude extract (n=8,  * P <0.05, ANOVA)     Nahrevanian et al.: In Vivo Antimalarial Effects of…    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         12       Fig. 2:  Plasmodium berghei  blood - stage forms in  G eimsa stained smears from mice .   The clinical diagnosis was confirmed by laboratory demons tration of the malaria parasite in  the stained smears. Parasitaemia was determined using blood smears stained with Geimsa  stain. PRBC were counted in five different fields, each of approximately 200 cells. Results  are expressed as the mean percentage of er ythrocytes containing G eimsa positive bodies       Parasitaemia 1 3 5 7 9 11 13 15 17 19 21 0 5 10 15 20 25 30 35 40 45 50 55 60 65 Control Test Days after infection ** ** Percentage of Parasitaemia     Fig. 3:  Percentage of parasitaemia in smears from blood of malarial mice   Smears were dried in air, fixed by methanol and stained with Geimsa for counting of parasites  inside RBC by light microscopy, Test,  A . khorassanica  crude extract; Control, Drug vehicle  (n=10 mice/day/group , Student's  t - test, ** P <0.01)    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         13   Hepatomegaly Control Test 0.0 0.5 1.0 1.5 2.0 Entire liver weight (g) Splenomegaly Control Test 0.00 0.05 0.10 0.15 0.20 0.25 Entire spleen weight (g) Body Weight Day 0 Day 7 Day 14 0 10 20 30 Control Test Weeks after infection Body weight (g)     Fig. 4:   Toxicity assay and  pathophysiological changes induced by  A. khorassanica  crude ex - tract in malarial animals .  Pathophysiological changes incl uding body weight, hepatomegaly  and splenomegaly   were evaluated as indices of toxicity by crude extract of  A. khorassanica  in  control and malarial groups  (n=10 mice/day/group , Student's  t - test)       Nahrevanian et al.: In Vivo Antimala rial Effects of…    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         14   Table   1 :  The non - polar constituents obtained from extract of   A. khorassanica  by GC - MS .   The non - polar constituents obtained from  A. khorassanica  were assessed by GC - MS and  listed in this table, in which the percentage and retention indices of the component are given.       A.  khorassanica    (%W/W)   Retention indices    (RI)   Compound    0.6   899   n - nonane    0.5   947   dihydromyrcene    0.6   958   4 - methyl nonane    2.1   999   n - decane    4.0   1033   1,8 - cineole*    5.8   1102   cis - thujone    3.7   1114   trans - thujone*    2.7   1118   isophorone    7.8   1123   chrysanthenone    5.4   1143   champhore    1.1   1199   n - do decane    1.5   1398   n - tetradecane    2.8   1586   davanone    1.7   1600   n - hexadecane*    3.4   1717   beta - davanone - 2 - ol*    1.4   1800   n - octadecane*    7.4   1984   palmitic acid*    1.2   2000   n - eicosane*        Discussion     Malaria  is  one  of  the  most  serious  and  widespread  disease s   and   a s  malaria  vac - cines  remain  problematic,  chemotherapy  still is the most important weapon against  the disease. However, the increasing drug  resistance continues to be the main prob - lem ,   t herefore,  the  limited  clinical  reper - toire of effective drugs an d the emergence  of  multi - resistant  strains  substantiate  the  need for new anti - malarials   ( 7 ) .   The results of this study indicated  no  tox - icity in naïve mice  with even high dose of  A. khoras sanica  crude extracts, which con - firms its  low est  side effects.  Alt hough, t he  inhibitory  effects  of  the  A.  khorassanica   extract  on the early  decline of   P. berghei   parasitaemia  highlights  its  anti - malarial  activity,   however  t his  concept  no  longer  can be  observed in  the  late infection. This  may be due to the metabolic proce ss of  A.  khorassanica  crude extract by mice and re - duction of its concentration in body. Ma - laria  parasite  actually  decreases  body  weight  and  in crease s   hepatomegaly  and  splenomegaly.  Crude extract of  A. khoras - sanica  represented  its  anti - symptomatic  effec ts by stabilization of body, liver and  spleen weights.     In  this  study,  31   fractions  were  isolated  from  A. khorssanica  extract  and effective  components were identified by t he chemi - cal  analysis  of  extract  by  GC - MS.  The  highest percentages of the components  are  indicated  as  chrysanthenone  (7.8%),  palmitic  acid  (7.4%)  and  cis - thujone  (5.8%).  The most retention indice s  of the  component  are  given  as   n - eicosane ,  palmitic  acid  and  n - octadecane .   In  other Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         15   studies,  v arious  species  of  the  genus  Ar - temisia  are used fo r their pharmacological,  antimicrobial,  antioxidant  activity.  Three  species  of  this  genus,  A.  scoparia ,  A.  sieberi  and  A. aucheri  are widely distrib - uted in desert area of Iran  ( 27 ) .  This is the  first  report  on  application  of  A.  khors - sanica  extract  on   the   treatment of murine  malaria .   The  herbal  extract  was  success - fully tested  in vivo  for its anti - malarial ac - tivity  through  a rtemisin  composition ,  which is widely used as a standard malaria  therapy.  Although,  this  study  confirmed  anti - malarial effects  of  A .  k horssanica  ex - tracts  against murine malaria  in vivo   dur - ing early infection ,  however there   are   more   efficacies  on pathophysiological symptoms  by  this  medication.   These  observations  provide the basis for the traditional use of  this herb in treatments of ma laria disease  ( 58 ) .   The route of inoculation  is important factor  to  determine  herbal  efficacy.  Although,  s ubcutaneous  injection  was  used  in  this  study, other routes may be recommended  for  future  studies.  Moreover,  a ctive  de - rivatives  of  Artemisia   includin g  arte - mether, arteether and artesunate, which are  used for oral, intramuscular, rectal and in - travenous  administration  ( 59 ) .  More   in - vestigations  on  different  Plasmodia   and  animal  hosts  are  needed  to  better  clarify  anti - malarial  activity  of  Iranian  flora  A.  khorassanica   and  analysis  of  its  natural  components.      Acknowledgement s     This work was funded by Department of  Parasitology, Pasteur Institute of Iran and  collaboration with  Department of Applied  Chemistry, Islamic Azad University, Qom  Branch, Qom, Iran   and  Payame Noor Uni - versity  of  Tehran  centre ,  Iran .   We  thank  Department  of  Biochemistry,  Pasteur  In - stitute of Iran  for assistance in methodol - ogy.  The authors declare that they have no  conflicts of interest.      References     1 .   Hardman  JG,  Limbird  LE.  Drugs  us ed  in  the  chemotherapy  of  ma - laria. In:  Brunton  L,  Lazo  J,  Parker   K. editors.  The  Good man   and  Gil - man 's   pharmacol ogical  bases  of  therapeutics .   10th  ed.  New  York,  USA :   Mc  Graw - Hill;  2001 .  P.  1069 - 1100 .   2 .   Peter IT ,  Anatoli VK. The cur rent  global  malaria  situation ;   Malaria  parasite biology,  patho genesis  and  pro tection.  1 st   ed.  ASM     P ress.  WDC 1998.   3 .   Martin SA, Bygbjerg IC, Joil GB.  Are  multilateral  malaria  re search  and control programs the most suc - cessful? Lessons from the past 100  years  in  Africa.  Am  J  Trop   Med  Hyg .  2004;   2:   268 - 78.   4 .   Miller  LH ,  Good   MF,  Million  G.  Malaria  pathogenesis.  Biochem  Systemat Ecol og.  1994; 264: 1878 - 83.   5 .   More  CM.  Reaching  maturity - 25  years of the TDR. Parasitol Today .   2002;   16:   522 - 8.   6 .   David  AF,  Philip  JR,  Simon  LC,  Reto  B,  Solomon  N.  Antimalar ial  drug  discovery:  Efficacy  models  for compound screening. Nat Rev .   2004;   3:   509 - 20.   7 .   Turschner S ,  Efferth T . Drug re sis - tance in Plasmodium: natural prod - ucts  in  the  fight  against  malaria.   Mini  Rev  Med  Chem .   2009;   9:   206 - 12.     8 .   Ollia ro P, Cattani J ,  Wirth D.  Ma - laria, the submerged disease. J Am  Med   Ass oc.   1996; 275 :  230 – 3.   9 .   White N , Olliaro  P. Strategies for  the prevention of anti - ma larial drug  resistance:  rationale  for  combina - tion  therapy  for  malaria.  Parasitol  Today .  1996 ;  12 :  399 – 401.   10 .   He SP ,  Tan GY ,  Li G ,  Tan WM ,  Nan TG ,  Wang BM ,  Li ZH ,  Li QX .   Development of a sensitive mono - Nahrevanian et al.: In Vivo Antimalarial Effects of…    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         16   clonal  antibody - bas ed  en zyme - linked immunosorbent as say for the  antimalaria  active  in gredient  ar - temisinin  in  the  Chi nese  herb  Ar - temisia  annua   L.  A n al   Bioanal  Chem .   2009;   393:   1297 - 303.   11 .   Willoug hby  JA  Sr,  Sundar  SN ,  Cheung  M ,  Tin  AS ,  Modiano  J ,  Firestone  GL.   Artemisinin  blocks  prostate can cer growth and cell cycle  pro gression  by  disrupting  Sp1  in - teractions  with  the  cyclin - de pendent  kinase - 4  (CDK4)  pro moter  and  inhibiting CDK4  gene expression.   J  Biol Chem .  2009;   284:   2203 - 13.   12 .   Arsenault  PR ,  Wobbe  KK ,  Weathers PJ . Recent advances in ar - temisinin  production  through  het - erologous  expression.   Curr  Med  Chem .  2008;   15:   2886 - 96.   13 .   Klayman  DL,  Lin  AJ,  Acton  N,  Scovill JP, Hock JM, Milhous WK ,   Theoharides  AD.  Isolation  of  ar - temisinin  (qinghaosu)  from  Ar - temisia  annua   growing  in  the  United  States.  J   Nat  Prod .   1984;  47:   715 - 7.   14 .   Ro  DK ,  Ouellet  M ,  Paradise EM ,  Burd  H ,  Eng  D ,  Paddon  CJ ,  Newman  JD ,  Keasling  JD .   In duc - tion of multiple pleiotropic drug re - sistance genes in yeast engineered  to  produce  an  in creased  level  of  anti - malarial  drug  precursor,  ar - temisinic  acid.   BMC  Biotechnol .   2008;   8:   83.   15 .   de  Ridder  S ,  van  der  Kooy  F ,  Verpoorte R .  Artemisia annua  as a  self - reliant treatment for malaria in  developing countries.   J Ethnophar - macol .   2008;   120:   302 - 14.   16 .   Arab  HA ,  Rahbari S ,  Rassouli A ,  Moslemi MH ,  Khosravirad F .   De - termination  of  artemisinin  in  Ar - temisia sieberi  and anticoc cidial ef - fects of the plant extract in broiler  chickens.   Trop Anim Health Prod .   2006;   38:   497 - 503.   17 .   Romero MR ,  Serrano MA ,  Vallejo  M ,  Efferth T ,  Alvarez M ,  Marin JJ .  Antiviral effect of artemisinin from  Artemisia  an nua  against  a  model  member of the Flaviv iridae family,  the  bo vine  viral  diarrhoea  virus  (BVDV).   Planta  Med .   2006;   72:   1169 - 74.     18 .   Heywood VH ,  Humphries CJ. An - themideae  systematic  review .   In:  Heywood VH ,  Harbord JB ,  Turner  BL.  Ed itors.  The  biology  and  chemistry  of  the  composi tae.  2 nd   ed.  Academic Press, London, 1977;  C hapter 31,  p.  852 -  88.   19 .   White NJ . Qinghaosu (artemisi nin):  the price of success.   Science .  2008;   320:   330 - 4.   20 .   Liu C ,  Zhao Y ,  Wang Y . Ar temisi - nin : current state and per spectives  for biotechnological production  of  an antimalarial drug.   Appl Micro - biol Biotech nol .  2006;   72:   11 - 20.    21 .   Rechinger KH. Artemisia in Flora  Iranica.  In: Rechinger  KH,  Hedge  IC,  editors.  Compositae,  Chapter  158,  Akademische  Druck  and  Verlagsanatalt,  Graz,  Austria,  1986;  p.  214.   22 .   Rezaeinodehi  A ,  Khangholi  S .   Chemical  composition  of  the  es - sential oil of Artemisia absin thium  growing  wild  in  Iran.   Pak  J  Biol  Sci.  2008;   11:   946 - 9.   23 .   Khangholil S ,  Rezaeinodehi A . Ef - fect  of  drying  temperature  on  es - sential oil content and compo sition  of  sweet  wormwood  ( Ar temisia  annua ) growing wild in Iran. Pak J  Biol Sci .  2008;   11:   934 - 7.   24 .   Maleki  A ,  Zarasvand  MA .  Heavy  metal s in selected edible vegetables  and estimation of their daily intake  in  Sanandaj,  Iran.   S E   Asn J Trop  Med Pub Heal th .  2008;   39:   335 - 40.   25 .   Asgary  S ,  Dinani  NJ ,  Madani  H ,  Mahzouni  P .   Et hanolic  extract  of  Artemisia aucheri  induces re gres sion  of  aorta  wall  fatty  streaks  in Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         17   hypercholesterolemic  rabbits.   Phar - mazie .  2008;   63:   394 - 7.   26 .   Jalali Heravi M ,  Sereshti H .  De ter - mination  of  essential  oil  com po - nents  of  Artemisia  haussknechtii  Boiss.  using  si multaneous  hydro - distillation - static  headspace  liquid  phase  microextraction - gas  chro - matog raphy  mass  spectrometry.   J  Chromatog A .  2007;   1160:   81 - 9.   27 .   Farzaneh  M ,  Ahmadzadeh  M ,  Hadian  J ,  Tehrani  AS .  Chemical  composition and antifungal ac tivity  of the essential oils of three species  of  Artemisia  on  some  soil - borne  phytopatho gens.   Commun  Agric  Appl  Biol  Sci .   2006;   71(Pt  B):   1327 - 33.   28 .   Bagheri R ,  Chaichi MR ,  Mohseni - Saravi  M ,  Amin  GR ,  Zahedi  G .  Grazing  affects  essen tial  oil  com - positions  of  Ar temisia  sieberi  Besser.   Pak  J   Biol  Sci .   2007;   10:   810 - 1 3.   29 .   Gu JD, Chen KX, Jiang HL, Ji RY.  A model molecule study of the O - centered  and  the  C - cen tered  free  radical  intermediates  of  artemisi - nin. Mol. Struct (Theochem) 1999;  459 :  103.   30 .   Gu,  JD,  Chen  KX,  Jiang  H L,   Leszczynski J. The Rad ical Trans - formation  in  Artemisinin:  A  DFT  Study.  J   Physical  Chem istry  Part  A .   1999; 103 :  9364.   31 .   Castilho  PC ,  Gouveia  SC ,  Rodrigues AI . Quantificatio n of ar - temisinin  in  Artemisia  annua   ex - tracts  by  1H - NMR.  Phytochem  Anal  2008;   19:   329 - 3 34.     32 .   Ma C ,  Wang H ,  Lu X ,  Li H ,  Liu B ,  Xu G .   Analysis of  Artemisia annua   L.  volatile  oil  by  compre hensive  two - dimensional  gas  chromatogra - phy  time - of - flight  mass  spec - trometry.  J  Chroma togr  A .   2007;   1150:   50 - 3.    33 .   Haynes  RK .  From  artemisinin  to  new artemisinin antimalarials: bio - synthesis, extract ion, old  and  new  derivatives,  stereochemistry  and  medicinal  chemistry  re quirements.  Curr Top Med Chem .  2006;   6:   509 - 37.    34 .   Vyas  N,  Avery  BA,  Avery  MA ,   Wyandt   CM.  Carrier - Mediated   Partitioning  of  Artemisinin  into  Plasmodium  falciparum - In fected  Erythrocytes.  Antimicrob  Agent  Chemoth .  2002; 46 :  105 - 9.    35 .   Meschnick  SR,  Taylor  TE,  Kam - chonwongpaisan  S.  Ar temisinin  and the antimalarial endoperoxides:  from  herbal  remedy  to  targeted  chemo ther apy.   Microbiol Mol Biol  Rev .  1996; 60 :  301 - 15.   36 .   Bhattacharya  A,  Mishra   LC ,   Bhasin   VK.  In  v itro  a ctivity of  a r - temisinin  in  combination  with  c lotrimazole  or  h eat - treated  a m - photericin  B  against  Plasmo dium  falciparum .    Am  Soc  Trop  Med  Hyg .  2008; 78 :  721 - 8.   37 .   Meshnick SR .  Artemisinin: mecha - nisms  of  action,  resistance  and  toxicity.  Int J   Parasitol .  2002; 32 :   1655 – 60.   38 .   Asawamahasakda  W,  Benakis  A,  Meshnick  SR.  The  interac tion  of  artemisinin  with   red  cell  mem - branes.  J   Lab   Clin Med .  1994; 123:  757 – 62.   39 .   Bhisutthibhan  J,  Pan  XQ,  Hossler  PA,  Walker  DJ,  Yowell  CA ,   Carlton J ,  Dame JB ,  Meshnick SR .  The  Plasmodium  falciparum   translationally  con troll ed  tumor  protein  homolog  and  its  reaction  with the anti malarial drug artemisi - nin.  J   Biol  Chem .   1998;  273 :   16192 – 8.   40 .   Eckstein - Ludwig U, Webb RJ, Van  Goethem  ID,  East  JM,  Lee  AG,  Kimura M, O'Neill PM, Bray PG,  Ward SA, Kris hna S.  Artemisinins  target the  SERCA  of  Plasmodium  falciparum.   J  Nature  2003;  424 :   957 – 961.   Nahrevanian et al.: In Vivo Antimalarial Effects of…    Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         18   41 .   Mercereau - Puijalon O, Fandeur T.  Antimalarial  activity  of  ar temisi - nins: identification of a novel tar - get? Lancet .  2003; 362:  2035 – 6.   42 .   Rustaiyan  A,  Bamoniri  A,  Raf - fatrad M, Jakupovic J ,  Bohlman F.  Eudesmane  derivatives  and  highly  oxygenated  monoter penes  from  Iranian  Artemisia  species.  Phyto - chem .  1987; 26:   2307 - 10 .   43 .   Weyerstahl   P,  Schneider  S,  Mar - schall H ,  Rustaiyan A. The es sen - tial oil of  Artemisia   sieberi .  J  Flav  Frag .  1993; 8:  139 - 45.   44 .   Weyerstahl  P,  Schneider  S ,  Mar - schall   H ,   Rustaiyan  A.  Terpenes  and  Terpene  Derivatives,  XXXI.  New  B isabolene  d erivatives and a  Salsolene  Ketone  from  Ar temisia  si eberi   Bess.  Liebigs  An nalen  der  Chemie .  1993; 2:  111 - 6.   45 .   Rustaiyan A, Sigari H, Jaku povic J ,   Grenz M. A sesquiter pene lactone  from  Artemisia   diffusa . Phytochem .   1989; 28: 2723 - 5.   46 .   Rus taiyan  A,  Zare  K,  Ganji  MT ,   Sadri HA.  A melampolide and two  dihydro artemorin deriva tives from  Artemisia   gypsacea .  Phytochem .   1989; 28: 1535 - 6.   47 .   Rustaiyan  A,  Balalaei  S,  Moham - madi F, Masoudi S ,  Yari M. Com - parison  of  the  volatile  oils  of  Ar - temisia   santol ina  Schrenk and  Ar - temisia   gypsacea  Krasch., M. Pop.  et Lincz. ex Poljak. from Iran.  J  Ess  Oil  Res .  2000; 12: 330 - 2.   48 .   Rustaiyan  A,  Komeilizadeh  H,  Masoudi S, Monfared  A, Yari M,  Kardar M ,  Shahgholi  M. Composi - tion of the volatile oil of  Artemisia  deserti  Krash. and  Artemisia olive - riana  J. Gayex DC. from Iran. J Sci  IR Irn .  2000; 11 :  213 - 5.   49 .   Sefidkon F, Jalili A ,  Mirhaji T. Es - sential  oil  composition  of  three  Artemisia   spp.  from  Iran.  J   Flav  Frag .  2000; 17 :  150 - 2 .   50 .   Morteza - Semnani   K,   Akbar zadeh  M,  Moshiri  K . Essential oil compo - sition of  Artemisia   fragrans  Willd.  from  Iran.  J   Flav  Frag .   2005;  20:  330 - 1.   51 .   Nematollahi F, Rustaiyan A, Lari - jani K, Nadimi M ,  Masoudi S. Es - sential oil composition of  Artemisia  biennis   Wild.  and  Pulicaria  undu - late (L.)   C.A. Mey., two composi - tae  herbs  growing  wild  in  Iran.  J   Ess  Oil  Res .  2006;   18: 339 - 41.   52 .   Rustaiyan A,  Nahrevanian H,  Ka - zemi M .   A  new a ntimalarial  a gent;  Effect of  e xtracts of  Ar temisia dif - fusa   against  Plasmo dium  berghei .  Pharmacog Mag .  2009; 4: 1 - 7 .   53 .   Adams RP. Identificat ion of Es sen - tial Oil Components by Gas Chro - matography  /  Quadrupole  Mass  Spectroscopy.  Allured  Publishing  Corporation, Carol Stream, Illinois,  2001; 61 - 424.   54 .   Nahrevanian H, Dascombe MJ .  Ni - tric oxide and reactive nitro gen in - termediates during lethal and  non - lethal  strains  of  murine  malaria .   Parasit  Immunol .   2001;  23:  491 - 501.   55 .   Nahrevanian H, Dascombe MJ .  Ex - pression  of  inducible  nitric  oxide  synthase  (iNOS)  mRNA  in  target  organs  of  lethal  and  non - lethal  strains  of  murine  mala ria.  Parasit  Immunol .  2002 ; 24 : 471 - 8.   56 .   Nahrevanian  H,  Farahmand  M,   Aghighi Z, Assmar M, Amirk hani  A .   Pharmacological  evaluation  of  anti - leishmanial activity by in vivo  nitric  oxide  modulation  in  Balb/c  mice  in fected  with  Leishmania  major  MRHO/IR/75/ER;  An  Ira - nian strain of cutaneous  leishmani - asis. Exp Parasitol .  2007 ; 116:  233 - 40.     57 .   Dascombe  MJ,  Nahrevanian  H .   Pharmacological assessment of the  role of nitric oxide in mice infected  with lethal and nonlethal species of Iranian J Parasitol: Vol. 5, No.1, 2010, pp.  6 - 19         19   malaria .   Parasit  Immunol .   2003 ;  25: 149 - 59.   58 .   Yazdanparast  R ,  Shahriyary  L .  Comparative  effects  of  Ar temisia  dracunculus, Satureja hortensis and  Origanum  majo rana  on  inhibition  of  blood  platelet  adhesio n,  aggre - gation  and  secretion.  Vascul  Pharmacol .  2008;   48:   32 - 7.   59 .   van Agtmael MA ,  Eggelte TA ,  van  Boxtel CJ .  Artemisinin drugs in  the  treatment of ma laria: from medici - nal  herb  to  registered  medication.   Trends  Pharmacol  Sci .   1999;   20:   199 - 205.                Nahrevanian et al.: In Vivo Antimalarial Effects of…    